The expression of the former correlated with tumor depth of invasion, lymph node and distant metastasis, TNM stage, high S100A5 expression, and poor prognosis, suggesting that ANXA2 and S100A6 may serve as prognostic indicators in GC patients [65]. The gene discussed is ANXA2; the disease is neoplasm.